---
url: https://www.servicesaustralia.gov.au/fabry-disease
title: Fabry disease - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:34.865Z
source: servicesaustralia.gov.au
---
# Fabry disease

The PBS subsidises migalastat for patients with Fabry disease.

## on this page

-   [Patient eligibility](#a1)
-   [Treatment specifics](#a2)
-   [Authority applications](#a3)
-   [More information](#a4)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with migalastat under the _National Health Act 1953_, section 85 for patients with Fabry disease.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing migalastat.

## Treatment specifics

To be eligible for PBS-subsidised treatment with migalastat, patients must be treated by a physician with expertise in the management of Fabry disease.

## Authority applications

### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial authority approval to prescribe PBS-subsidised migalastat to treat Fabry disease can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [Fabry disease - migalastat - initial authority application form](/pb373?context=20)
-   relevant attachments.

### Applying for initial grandfather treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial grandfather authority approval to prescribe PBS-subsidised migalastat can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [Fabry disease - migalastat - initial grandfather authority application form](/pb374?context=20)
-   relevant attachments.

### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsided migalastat to treat Fabry disease can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
